###begin article-title 0
Estrogen receptor-alpha gene haplotype is associated with primary knee osteoarthritis in Korean population
###end article-title 0
###begin p 1
###xml 285 287 281 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 319 321 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 637 640 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 661 664 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 688 691 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 942 945 930 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 1114 1118 1102 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P = </italic>
###xml 1290 1292 1276 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1301 1303 1287 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 783 791 <span type="species:ncbi:9606">patients</span>
###xml 1024 1032 <span type="species:ncbi:9606">patients</span>
###xml 1229 1237 <span type="species:ncbi:9606">patients</span>
###xml 1336 1344 <span type="species:ncbi:9606">patients</span>
Estrogen and estrogen receptors (ERs) are known to play important roles in the pathophysiology of osteoarthritis (OA). To investigate ER-alpha gene polymorphisms for its associations with primary knee OA, we conducted a case-control association study in patients with primary knee OA (n = 151) and healthy individuals (n = 397) in the Korean population. Haplotyping analysis was used to determine the relationship between three polymorphisms in the ER-alpha gene (intron 1 T/C, intron 1 A/G and exon 8 G/A) and primary knee OA. Genotypes of the ER-alpha gene polymorphism were determined by PCR followed by restriction enzyme digestion (PvuII for intron 1 T/C, XbaI for intron 1 A/G, and BtgI for exon 8 G/A polymorphism). There was no significant difference between primary knee OA patients and healthy control individuals in the distribution of any of the genotypes evaluated. However, we found that the allele frequency for the exon 8 G/A BtgI polymorphism (codon 594) was significantly different between primary knee OA patients and control individuals (odds ratio = 1.38, 95% confidence interval = 1.01-1.88; P = 0.044). In haplotype frequency estimation analysis, there was a significant difference between primary knee OA patients and control individuals (degrees of freedom = 7, chi2 = 21.48; P = 0.003). Although the number OA patients studied is small, the present study shows that ER-alpha gene haplotype may be associated with primary knee OA, and genetic variations in the ER-alpha gene may be involved in OA.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 297 298 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 388 389 388 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL1A1</italic>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL2A1</italic>
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL9A1</italic>
###xml 523 530 523 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL11A2</italic>
###xml 584 588 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CMP1</italic>
###xml 611 614 611 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VDR</italic>
###xml 647 651 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF1</italic>
###xml 685 687 682 684 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 688 696 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TGF&#946;1</italic>
###xml 711 715 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGC1</italic>
###xml 759 764 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TIMP3</italic>
###xml 791 795 785 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL1R</italic>
###xml 825 826 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Osteoarthritis (OA) is a common disorder among the elderly. It is multifactorial disorder, with predisposing factors included advanced age, and genetic, hormonal and mechanical factors [1,2]. Furthermore, recent studies have revealed a role for the inflammatory process in the pathogenesis of OA [3-5]. It has been reported that the development of OA may be influenced by multiple genes [6]. A number of candidate genes have been suggested to mediate susceptibility to OA, including collagen genes (COL1A1, COL2A1, COL9A1, COL11A2), and the genes encoding cartilage matrix protein 1 (CMP1), vitamin D receptor (VDR), insulin-like growth factor-1 (IGF1), transforming growth factor-beta1 (TGFbeta1), aggrecan-1 (AGC1), tissue inhibitor of metalloproteinase 3 (TIMP3), interleukin-1 receptor (IL1R), and the estrogen receptor [6].
###end p 3
###begin p 4
###xml 240 241 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 314 315 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 402 403 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 512 513 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 635 637 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human estrogen receptor (ER) has two isoforms: ER-alpha and ER-beta. The former isoform is a ligand-activated transcription factor composed of several important domains for hormone binding, DNA binding, and activation of transcription [7]. ER-alpha is an important mediator in the signal transduction pathway [7]. The ER is a member of the steroid/thyroid hormone superfamily of nuclear receptors [8]. The ER-alpha gene is greater than 140 kilobases, contains eight exons, and is located on chromosome 6q25 [9]. The coding region has a length of 1785 nucleotides, and it is translated into a protein of 595 amino acids and 66 kDa [10].
###end p 4
###begin p 5
###xml 80 82 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 83 85 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 233 235 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 281 284 273 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 291 294 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 387 389 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 427 430 411 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 437 440 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 539 541 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 635 638 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 723 725 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 743 746 723 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 844 846 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 925 928 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 999 1001 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1027 1029 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 893 901 <span type="species:ncbi:9606">patients</span>
Several variations in the DNA sequence of the ER-alpha gene have been reported [11,12]. A few reports have examined the association between ER-alpha gene polymorphisms and OA; the findings are controversial. Ushiyama and co-workers [13] reported associations between a genotype of PvuII and XbaI polymorphisms in intron 1 of the ER-alpha gene and generalized OA. Bergink and co-workers [14] found that an ER-alpha haplotype of PvuII and XbaI polymorphisms was associated with radiographic OA of the knee. However, Loughlin and co-workers [15] found no association between ER-alpha gene polymorphisms and idiopathic OA. Some studies of BtgI polymorphisms have been conducted in other diseases. Cancel-Tassin and co-workers [16] reported that a BtgI (594 A/G) polymorphism was not associated with risk for prostate cancer. Tanaka and colleagues [17] reported similar findings in prostate cancer patients. In another study, the BtgI (594 A/G) polymorphism was not associated with renal cell carcinoma [18]. Curran and co-workers [19] reported an association of A/G polymorphism in exon 8 of the ER gene with sporadic breast cancer. However, no findings regarding the relationship between exon 8 A/G polymorphism and OA have been reported.
###end p 5
###begin p 6
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 328 331 324 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 347 350 343 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 369 372 365 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
In the present study, we first analyzed the association between the exon 8 G/A BtgI polymorphism (database-single nucleotide polymorphism number rs2228480; codon 594) of the ER-alpha gene and primary knee OA in patients from the Korean population. We also investigated the association between haplotypes of three polymorphisms (PvuII in intron 1, XbaI in intron 1, and BtgI in exon 8) and primary knee OA.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Study subjects
###end title 8
###begin p 9
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 49 54 <span type="species:ncbi:9606">women</span>
###xml 62 65 <span type="species:ncbi:9606">men</span>
###xml 122 130 <span type="species:ncbi:9606">Patients</span>
###xml 265 270 <span type="species:ncbi:9606">women</span>
###xml 279 282 <span type="species:ncbi:9606">men</span>
A total of 151 patients with primary knee OA (98 women and 53 men) from the Korean population were included in the study. Patients were examined at the Rheumatology Clinic in Kyung Hee University Medical Center, Seoul, Korea. In total, 397 control individuals (207 women and 190 men) underwent the 2003 health examination. OA was diagnosed according to American College of Rheumatology criteria, which include primary OA with any symptom and/or sign of OA, positive finding on radiographs according to the Kellgren-Lawrence grading [20], and no evidence of arthritis due to other disease. The study was approved by the ethics review committee of the Medical Research Institute, Kyung Hee University Medical Center, Seoul, Korea.
###end p 9
###begin p 10
###xml 274 282 <span type="species:ncbi:9606">patients</span>
###xml 365 373 <span type="species:ncbi:9606">patients</span>
Clinical information and classification of primary knee osteoarthritisThe age at onset of OA is important clinically because it is associated with long-term prognosis. During the study, we were able to identify the current age and age at onset of disease in the 151 knee OA patients by individual interview conducted at our outpatient clinic. The current age of OA patients (mean +/- standard deviation) was 58.8 +/- 9.6 years, and the age at onset of OA was 52.0 +/- 9.5 years. We therefore stratified clinical data according to mean onset age of disease: older or younger than 52.0 years. The group with disease onset at age <52.0 years was defined as the 'early' onset, and the group of disease onset at age >52.0 years was defined as the 'late' onset group.
###end p 10
###begin p 11
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 502 503 502 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 354 362 <span type="species:ncbi:9606">patients</span>
The Kellgren-Lawrence grade represents disease severity, as reflected on radiographs, and Lequesne's functional index represents functional or symptomatic status of patients [21]. Radiographic findings of OA were classified into mild (Kellgren-Lawrence grade 1 or 2) or severe (Kellgren-Lawrence grade 3 or 4). The functional or symptomatic status of OA patients was classified as functionally or symptomatically good (Lequesne's functional index = 10) or poor (Lequesne's functional index > 10; Table 1).
###end p 11
###begin title 12
Analysis of estrogen receptor-alpha gene polymorphisms
###end title 12
###begin p 13
###xml 436 437 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 701 702 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 703 705 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 706 708 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 510 516 <span type="species:ncbi:9913">bovine</span>
Genomic DNA was prepared from whole blood samples using the NucleoSpin DNA isolation kit (Macherey-Nagel GmbH & Co., Duren, Germany). PCR amplifications were performed using 50 ng genomic DNA in a 30 mul reaction volume containing 0.5 mul 10 pmol sense primer, 0.5 mul 10 pmol antisense primer, 0.5 mul 2.5 mmol/l dNTP (Takra, Shiga, Japan), 1 U Taq DNA polymerase (Neurotics Inc., Seoul, Korea), and in buffer containing 25 mmol/l MgCl2, 750 mmol/l Tris-HCl (pH 9.0), 150 mmol/l ammonium sulfate, and 1 mg/ml bovine serum albumin. Samples were subjected to 35 cycles of amplification in GeneAmp PCR system 2700 (Applied Biosystems, Foster, CA, USA). PCR primers used in the study are listed in Table 2[19,22]. The PCR products were digested under the conditions specified by the enzyme supplier (New England Biolabs Inc, Beverly, MA, USA). Restriction fragments were separated by agarose gel electrophoresis and ethidium bromide staining.
###end p 13
###begin title 14
Statistical analysis
###end title 14
###begin p 15
###xml 186 188 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 219 221 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 285 287 283 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
For the case-control association study, the significance of differences in allelic and genotypic frequencies between OA patients and control populations was determined using standard chi2 tests. We used the EH program [23] to investigate the relative risks associated with haplotypes. P < 0.05 was considered statistically significant.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Distribution of estrogen receptor-alpha genotypes in osteoarthritis patients and control individuals
###end title 17
###begin p 18
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 169 172 165 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 350 352 346 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 483 485 479 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 556 559 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 583 586 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 686 687 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 806 809 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 826 828 822 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 853 856 849 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 872 874 868 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 901 904 897 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 920 922 916 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
###xml 449 457 <span type="species:ncbi:9606">patients</span>
###xml 646 654 <span type="species:ncbi:9606">patients</span>
As shown in Table 3, three single nucleotide polymorphisms were identified in ER-alpha intron 1 (T/C, A/G) and exon 8 (G/A). When the allele frequency of the exon 8 G/A BtgI polymorphism was compared between OA patients and control individuals, a significant difference was observed (odds ratio [OR] = 1.38, 95% confidence interval [CI] = 1.01-1.88; P = 0.044). However, the genotype distribution did not exhibit a significant difference between OA patients and control individuals (P = 0.13). Observed genotype and allele frequencies for the intron 1 T/C PvuII and the intron 1 A/G XbaI polymorphisms were not significantly different between OA patients and control individuals (Table 3). There was no evidence of deviation from Hardy-Weinberg equilibrium in healthy control individuals (for intron 1 T/C PvuII polymorphism, P = 0.85; for intron 1 A/G XbaI polymorphism, P = 0.99; and for exon 8 G/A BtgI polymorphism, P = 0.77).
###end p 18
###begin title 19
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Estrogen receptor-alpha gene polymorphisms and sex of osteoarthritis patients
###end title 19
###begin p 20
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 57 59 57 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 120 122 120 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 149 152 149 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
###xml 509 517 <span type="species:ncbi:9606">patients</span>
As shown in Table 4, the observed genotype distribution (P = 0.04) and allele frequency (OR = 1.89, 95% CI = 1.15-3.11; P = 0.01) for the exon 8 G/A BtgI polymorphism were significantly different between male OA patients and male control individuals, whereas those in females exhibited no significant difference. We compared genptype distributions and allele frequencies for the intron 1 T/C PvuII and the intron 1 A/G XbaI polymorphisms. There were no significant differences in the polymorphisms between OA patients and controls of the same sex.
###end p 20
###begin title 21
Estrogen receptor-alpha gene polymorphisms and risk for late onset osteoarthritis
###end title 21
###begin p 22
###xml 216 219 216 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 360 362 360 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 493 495 493 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 574 577 574 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 790 793 790 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 814 817 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 839 842 839 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 961 962 961 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 459 467 <span type="species:ncbi:9606">patients</span>
###xml 675 683 <span type="species:ncbi:9606">patients</span>
###xml 881 889 <span type="species:ncbi:9606">patients</span>
Late onset OA patients were defined as those with disease onset at age above 52 years, whereas early onset OA patients had their disease onset at age under 52 years. When comparing allele frequency of the exon 8 G/A BtgI polymorphism between late onset OA patients and control individuals, a significant difference was observed (OR = 1.62, 95% CI = 1.07-2.46; P = 0.021). However, the genotype distribution did not exhibit a significant difference between OA patients and control individuals (P = 0.06). The genotype distributions and allele frequencies of the intron 1 T/C PvuII and the intron 1 A/G XbaI polymorphisms were not significantly different between late onset OA patients and control individuals. When comparing genotype distributions and allele frequencies of the intron 1 T/C PvuII, the intron 1 A/G XbaI, and the exon 8 G/A BtgI polymorphisms between early onset OA patients and control individuals, no significant difference was observed (Table 4).
###end p 22
###begin title 23
Estrogen receptor-alpha gene polymorphisms and risk for radiographically severe osteoarthritis
###end title 23
###begin p 24
###xml 266 269 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 509 512 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
###xml 625 633 <span type="species:ncbi:9606">patients</span>
Patients with radiographically severe OA were defined as those whose Kellgren-Lawrence grade was 3 or 4, whereas radiographically mild OA was defined as Kellgren-Lawrence grade 1 or 2. When comparing genotype distributions and allele frequencies of the intron 1 T/C PvuII, the intron 1 A/G XbaI, and the exon 8 G/A BtgI polymorphisms between patients with mild OA and control individuals, no significant difference was observed (Table 4). The genotype distributions and allele frequencies of the intron 1 T/C PvuII, the intron 1 A/G XbaI, and the exon 8 G/A BtgI polymorphisms did not exhibit significant differences between patients with severe OA and control individuals (Table 4).
###end p 24
###begin title 25
Estrogen receptor-alpha gene polymorphisms and risk for functionally poor osteoarthritis
###end title 25
###begin p 26
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 376 379 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 401 404 401 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 545 546 545 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
OA patients who were functionally or symptomatically poor (poor index) were defined as those who with a Lequesne's functional index score over 10, whereas those who were functionally or symptomatically good (good index) had a Lequesne's functional index score less than or equal to 10. Genotype distributions and allele frequencies of the intron 1 T/C PvuII, the intron 1 A/G XbaI, and the exon 8 G/A BtgI polymorphisms between OA patients with a good and those with a poor index, and control individuals were not significantly different (Table 4).
###end p 26
###begin title 27
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Estrogen receptor-alpha haplotype analysis in patients with primary knee osteoarthritis
###end title 27
###begin p 28
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 168 170 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 179 181 177 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 294 296 290 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 304 306 300 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 425 427 419 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 436 438 430 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 453 454 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 242 250 <span type="species:ncbi:9606">patients</span>
###xml 375 383 <span type="species:ncbi:9606">patients</span>
Table 5 shows the frequency of each haplotype. The difference was significant between all OA patients combined and control individuals (degrees of freedom [df] = 7, chi2 = 21.48; P = 0.003). There was no significant difference between female patients and female control individuals (df = 7, chi2 = 8.22; P = 0.31). However, there was a significant difference between male OA patients and male control individuals (df = 7, chi2 = 16.76; P = 0.019; Table 5).
###end p 28
###begin p 29
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 259 261 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 270 272 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 362 364 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 372 374 368 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 515 517 509 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 526 528 520 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 618 620 610 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 629 631 621 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 750 752 740 742 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 761 763 751 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 845 847 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 856 858 844 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 873 874 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 195 203 <span type="species:ncbi:9606">patients</span>
###xml 297 305 <span type="species:ncbi:9606">patients</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
###xml 567 575 <span type="species:ncbi:9606">patients</span>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
###xml 806 814 <span type="species:ncbi:9606">patients</span>
The late onset, radiographically severe, and poor index subgroups of OA patients exhibited significant differences in haplotype distribution (Table 6). There was a significant difference between patients with late onset OA and control individuals (df = 7, chi2 = 21.96; P = 0.002) but not between patients with early onset OA and control individuals (df = 7, chi2 = 7.42; P = 0.390). When comparing patients with radiographically severe OA and control individuals, a significant difference was observed (df = 7, chi2 = 23.96; P = 0.001), but this was not the case in patients with radiographically mild OA (df = 7, chi2 = 13.60; P = 0.059). There was a significant difference between OA patients with a poor index and control individuals (df = 7, chi2 = 14.66; P = 0.041), but this was not the case for OA patients with a good index (df = 7, chi2 = 10.96; P = 0.140; Table 6).
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 169 172 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 188 191 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 210 213 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 290 292 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 293 295 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 296 298 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 299 301 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 505 507 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 508 510 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 599 601 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 646 649 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 656 659 640 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 917 919 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 957 960 937 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 967 970 947 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 1184 1186 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 773 781 <span type="species:ncbi:9606">patients</span>
###xml 1145 1153 <span type="species:ncbi:9606">patients</span>
We report here, for the first time, on the associations of exon 8 G/A BtgI polymorphism (codon 594) in the ER-alpha gene and ER-alpha haplotypes of three polymorphisms (PvuII in intron 1, XbaI in intron 1, and BtgI in exon 8) with primary knee OA in the Korean population. Several reports [13-15,24-26] have indicated that estrogen and its receptor might be involved in the etiology of OA. Until now three reports on the relationship between ER-alpha polymorphisms and OA had been published. Two studies [13,14] reported that a ER-alpha polymorphism was associated with OA. Ushiyama and co-workers [13] found an association between a genotype of PvuII and XbaI polymorphisms in intron 1 and generalized OA with severe radiographic changes in the Japanese population (65 OA patients and 318 control individuals). In a population-based study conducted in a Caucasian population (1483 subjects), Bergink and co-workers [14] reported that ER-alpha haplotype of PvuII and XbaI polymorphisms was associated with radiographic OA of the knee. One study showed no relationship between ER-alpha gene polymorphisms and OA in a Caucasian population (371 OA patients and 369 control individuals) [15].
###end p 31
###begin p 32
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 251 254 251 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 901 902 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 1335 1337 1335 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 1366 1368 1366 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 394 402 <span type="species:ncbi:9606">patients</span>
###xml 442 450 <span type="species:ncbi:9606">patients</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 1034 1042 <span type="species:ncbi:9606">patients</span>
###xml 1161 1169 <span type="species:ncbi:9606">patients</span>
###xml 1187 1195 <span type="species:ncbi:9606">patients</span>
###xml 1356 1364 <span type="species:ncbi:9606">patients</span>
Our study showed that the genotype distributions for the intron 1 T/C PvuII and the intron 1 A/G XbaI polymorphisms were not associated with OA, a finding similar to that reported by Loughlin and co-workers [15]. However, the allele frequency for the BtgI polymorphism was significantly different between OA and control individuals. The difference in the allele frequency was more marked in OA patients with late onset of disease and in male patients (Table 4). The haplotype of three polymorphisms was associated with OA. We conducted further analysis of OA patients subdivided by clinical parameters and found that the haplotype exhibited a strong association with late onset, radiographically severe, and functionally poor OA of the knee, and in particular with male sex (Tables 5 and 6). However, the TAA and CAG haplotypes exhibited differences between female and male control individuals (Table 5). Haplotype TAA had frequencies of 0.12 and 0.05 in female and male control individuals, but its frequencies in male and female OA patients were 0.18 and 0.14, respectively. Haplotype CAG had a frequency of 0.18 in female control individuals, 0.18 in female patients and 0.18 in male patients, but its frequency in the male control individuals was 0.31. This discrepancy may be due to the small numbers of male control individuals (n = 190) and male OA patients (n = 53).
###end p 32
###begin p 33
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 140 142 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 143 145 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 302 304 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 337 340 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 393 396 389 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pvu</italic>
###xml 412 415 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 434 437 430 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Btg</italic>
###xml 477 480 <span type="species:ncbi:9606">men</span>
###xml 492 497 <span type="species:ncbi:9606">women</span>
The genotype distribution of the PvuII and XbaI polymorphisms in the ER-alpha gene was reported to differ between racial and ethnic groups [13-15]. In the present study, genotype and allele frequencies in control individuals were similar to previously reported distributions in the Chinese population [27]. Interestingly, the exon 8 G/A BtgI polymorphism and haplotype of three polymorphisms (PvuII in intron 1, XbaI in intron 1, and BtgI in exon 8) were associated with OA in men but not in women.
###end p 33
###begin p 34
Our sample size was relatively small and our data were subjected to a number of uncorrected tests, and therefore our positive results may represent false-positive findings. To confirm the association between ER-alpha polymorphisms and OA, additional studies are required.
###end p 34
###begin title 35
Conclusion
###end title 35
###begin p 36
In conclusion, we found that ER-alpha gene haplotype may be associated with primary knee OA in the Korean population, and that genetic variations in the ER-alpha gene might play a role in susceptibility to OA.
###end p 36
###begin title 37
Competing interests
###end title 37
###begin p 38
None declared.
###end p 38
###begin title 39
Abbreviations
###end title 39
###begin p 40
CI = confidence interval; df = degrees of freedom; ER = estrogen receptor; OA = osteoarthritis; OR = odds ratio; PCR = polymerase chain reaction.
###end p 40
###begin title 41
Acknowledgements
###end title 41
###begin p 42
This study was supported by an Oriental Medicine Research Center for Bone and Joint Disease grant from the Ministry of Health and Welfare of the Republic of Korea (03-PJ9-PG6-SO01-0002).
###end p 42
###begin article-title 43
Vascular mechanisms in osteoarthritis
###end article-title 43
###begin article-title 44
The role of structural genes in the pathogenesis of osteoarthritic disorders
###end article-title 44
###begin article-title 45
Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets
###end article-title 45
###begin article-title 46
Immunologic intervention in the pathogenesis of osteoarthritis
###end article-title 46
###begin article-title 47
Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis
###end article-title 47
###begin article-title 48
Genomics of osteoarthritis
###end article-title 48
###begin article-title 49
###xml 69 74 <span type="species:ncbi:9606">human</span>
Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors
###end article-title 49
###begin article-title 50
The steroid and thyroid hormone receptor superfamily
###end article-title 50
###begin article-title 51
Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique
###end article-title 51
###begin article-title 52
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
###end article-title 52
###begin article-title 53
Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility
###end article-title 53
###begin article-title 54
Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations
###end article-title 54
###begin article-title 55
Estrogen receptor gene polymorphism and generalized osteoarthritis
###end article-title 55
###begin article-title 56
###xml 109 112 <span type="species:ncbi:9606">men</span>
###xml 117 122 <span type="species:ncbi:9606">women</span>
Estrogen receptor alpha gene haplotype is associated with radiographic osteoarthritis of the knee in elderly men and women
###end article-title 56
###begin article-title 57
Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis
###end article-title 57
###begin article-title 58
###xml 42 47 <span type="species:ncbi:9606">human</span>
Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk
###end article-title 58
###begin article-title 59
Polymorphisms of estrogen receptor alpha in prostate cancer
###end article-title 59
###begin article-title 60
###xml 58 63 <span type="species:ncbi:9606">human</span>
Single nucleotide polymorphisms of estrogen receptor a in human renal cell carcinoma
###end article-title 60
###begin article-title 61
Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer
###end article-title 61
###begin article-title 62
Radiological assessment of osteoarthritis
###end article-title 62
###begin article-title 63
Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests
###end article-title 63
###begin article-title 64
Association study of oestrogen receptor alpha gene polymorphism and suicidal behaviours in major depressive disorder
###end article-title 64
###begin article-title 65
Linkage disequilibrium between alleles at marker loci
###end article-title 65
###begin article-title 66
###xml 61 66 <span type="species:ncbi:9606">human</span>
Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes
###end article-title 66
###begin article-title 67
###xml 93 98 <span type="species:ncbi:9606">human</span>
Estrogen and osteoarthritis: a study of synovial estradiol and estradiol receptor binding in human osteoarthritic knees
###end article-title 67
###begin article-title 68
Generalized osteoarthritis: a hormonally mediated disease
###end article-title 68
###begin article-title 69
Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast cancer study
###end article-title 69
###begin title 70
Figures and Tables
###end title 70
###begin p 71
###xml 32 40 <span type="species:ncbi:9606">patients</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Clinical characteristics of the patients with primary knee osteoarthritis patients
###end p 71
###begin p 72
###xml 15 23 <span type="species:ncbi:9606">patients</span>
A total of 151 patients with primary knee osteoarthritis were included. Values are expressed as mean +/- standard deviation or as numbers.
###end p 72
###begin p 73
Sequences of primers used for estrogen receptor-alpha genotyping
###end p 73
###begin p 74
bp, base pairs.
###end p 74
###begin p 75
###xml 92 100 <span type="species:ncbi:9606">patients</span>
Genotype distribution and allele frequency of estrogen receptor-alpha gene polymorphisms in patients with osteoarthritis and control individuals
###end p 75
###begin p 76
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 155 157 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 192 193 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 242 244 238 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
A total of 151 patients with osteoarthritis (OA) and 397 control individuals were included in the study. aControl individuals versus patients using the chi2 test with 3 x 2 contingency table. bControl individuals versus patients using the chi2 test with 2 x 2 contingency table. CI, confidence interval; ER, estrogen receptor; OR, odds ratio.
###end p 76
###begin p 77
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Comparison of estrogen receptor-alpha gene polymorphisms in subtypes of osteoarthritis patients and control individuals
###end p 77
###begin p 78
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 38 40 36 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 75 76 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 113 115 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 150 151 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 329 330 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 477 478 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 16 24 <span type="species:ncbi:9606">patients</span>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 365 373 <span type="species:ncbi:9606">patients</span>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
###xml 606 614 <span type="species:ncbi:9606">patients</span>
aControl versus patients using the chi2 test with 3 x 2 contingency table. bControl versus patients using the chi2 test with 2 x 2 contingency table. cEarly onset osteoarthritis OA patients were defined as those with disease onset at age under 52 years, whereas late onset OA patients were those with onset at age over 52 years. dBased on radiographic findings, OA patients were classified into mild (Kellgren-Lawrence grade 1 or 2) or severe (Kellgren-Lawrence grade 3 or 4). eBased on Lequesne's functional index score, poor OA patients were defined as those with an index score over 10, whereas good OA patients had an index score less than or equal to 10.
###end p 78
###begin p 79
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Comparison of estrogen receptor-alpha gene haplotypes in osteoarthritis patients and control individuals
###end p 79
###begin p 80
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 141 143 141 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
A total of 397 control individuals and 151 osteoarthritis (OA) patients were included in the study. Values given are haplotype frequencies. aP values for overall difference in haplotype distribution between OA patients and control individuals were calculated using the EH program [23]. df, degrees of freedom.
###end p 80
###begin p 81
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Comparison of estrogen receptor-alpha gene haplotypes in subtypes of osteoarthritis patients and control individuals
###end p 81
###begin p 82
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 431 432 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 626 627 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 627 629 627 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
###xml 484 492 <span type="species:ncbi:9606">patients</span>
###xml 560 568 <span type="species:ncbi:9606">patients</span>
###xml 696 704 <span type="species:ncbi:9606">patients</span>
Values given are haplotype frequencies. aThe mean age at onset in the osteoarthritis (OA) patients was 52.0 years, and so early onset OA patients were defined as those with disease onset at age under 52 years, whereas late onset OA patients were those with onset at age over 52 years. bBased on radiographic findings, OA patients were classified as mild (Kellgren-Lawrence grade 1 or 2) or severe (Kellgren-Lawrence grade 3 or 4). cBased on Lequesne's functional index score, poor OA patients were defined as those with an index score over 10, whereas good OA patients were those with an index score less than or equal to 10. dP values for overall difference in haplotype distribution between OA patients and control individuals were calculated using the EH program [23]. df, degrees of freedom.
###end p 82

